Pacira BioSciences, Inc.
PCRX· Nasdaq
Released Aug 2, 2018, during market hours
10-Q filed Aug 2, 2018, 33 days after period end · 0001396814-18-000025
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $80.72M | $70.14M | $69.64M | $59.15M |
| Net Income | $2.56M | -$19.74M | -$7.96M | $8.00K |
| EPS Diluted | $0.06 |
Pacira BioSciences, Inc. · CIK 1396814 · Engraved from SEC EDGAR
| -$0.49 |
| -$0.21 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.